Role and timing of second-line therapies for patients with recurrent platinum-resistant ovarian epithelial cancer.

Liu, N F; Chen, Y Q; Hu, J L; Chen, G P; Zhu, T; Zhu, J Q; Yang, Y; Sun, H Y; Yu, H

Liu, N F; Chen, Y Q; Hu, J L; Chen, G P; Zhu, T; Zhu, J Q; Yang, Y; Sun, H Y; Yu, H.

Eur J Gynaecol Oncol ; 38(2): 266-270, 2017.

Article in En | MEDLINE | ID: mdl-29953793

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Drug Resistance, Neoplasm; Neoplasm Recurrence, Local/drug therapy; Neoplasms, Glandular and Epithelial/drug therapy; Ovarian Neoplasms/drug therapy; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Carcinoma, Ovarian Epithelial; Cisplatin/therapeutic use; Cytoreduction Surgical Procedures; Deoxycytidine/administration & dosage; Deoxycytidine/analogs & derivatives; Disease-Free Survival; Humans; Middle Aged; Neoplasm Recurrence, Local/surgery; Neoplasms, Glandular and Epithelial/surgery; Ovarian Neoplasms/surgery; Paclitaxel/therapeutic use; Response Evaluation Criteria in Solid Tumors; Retreatment; Retrospective Studies; Survival Rate; Topotecan/administration & dosage; Gemcitabine

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Neoplasms, Glandular and Epithelial / Drug Resistance, Neoplasm / Neoplasm Recurrence, Local Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Humans / Middle aged Language: En Journal: Eur J Gynaecol Oncol Year: 2017 Document type: Article Country of publication: Singapore

Search on Google

Add to My VHL

XML

PubMed Links